CRT 2017 : DES BIOABSORBABLE & DCB TECHNOLOGIES - DCB Technology Symposium - Coronary

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

DES BIOABSORBABLE & DCB TECHNOLOGIES - DCB Technology Symposium - Coronary

Featuring

  • Robert Byrne
  • Azeem Latib
  • Dean Kereiakes
  • Bruno Scheller
  • Bernardo Cortese
  • Tara Ryan

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

DCB for In-Stent Restenosis: Is It Superior to DES? - Robert Byrne
Is There Any Role of DCB for the Treatment of De Novo Lesions? - Azeem Latib
DCB as Adjunct Therapy to DES and BRS - Azeem Latib
The Virtue Micropore Drug Eluting Balloon - Dean Kereiakes
Long-Term Survival Benefit of DCB Versus DES for ISR Despite Angiographic Disadvantage of DCB - Bruno Scheller
Sirolimus Eluting Drug-Coated Balloons - Bernardo Cortese
Regulatory Considerations for Coronary Drug-Coated Balloons - Tara Ryan

Target Audience

Learning Objectives

Related Moments

Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides — The Case for Soluble ST2
Journal
Article on Novel Biomarkers in Heart Failure Beyond Natriuretic Peptides — The Case for Soluble ST2
CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Conference
Simple Education: Advances in Co-registration, Coronary Physiology & Intra Coronary Imaging, 7-8th November 2022, London
Course
7-8th November 2022, 2-day course in London
Supported By
Loading Simple Education